Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits

Annals of Thoracic Surgery

Volumn 65, Issue 2, 1998, Pages 425-433

  Aldea, Gabriel S ^a   O'Gara, Paul ^a   Shapira, Oz M ^a   Treanor, Patrick ^a   Osman, Ashraf ^a   Patalis, Eva ^a   Arkin, Charles ^a   Diamond, Rhea ^a   Babikian, Viken ^a   Lazar, Harold L ^a   Shemin, Richard J ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; HEPARIN; PROTHROMBIN; THROMBIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTICOAGULANTS; ANTITHROMBIN III; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROSPECTIVE STUDIES; PROTHROMBIN;

EID: 20244381088     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01347-7     Document Type: Article

References (24)

1. 1. Von Segesser LK, Weiss BK, Pasic M, et al. Risk and benefit of low systemic heparinization during open heart operations. Ann Thorac Surg 1994;58:391-8.
2. 2. Ovrum E, Holen EA, Tangen G, et al. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects. Ann Thorac Surg 1995; 60:365-71.
3. 3. Gu YJ, van Oeveren W, van der Kamp KWHJ, et al. Heparincoating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass. Perfusion 1991;6:221-5.
4. 4. Redmond JM, Gillinov AV, Stuart RS, et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 1993;56:474-9.
5. 5. Fosse E, Moen O, Johnson E, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994;58:472-7.
6. 6. Wendel HP, Heller W, Hoffmeister HE. Pathway of platelet protection in heparin-coated devices and its significance for cardiac surgery. Trans Soc Biomater 1995;21:281.
7. 7. Gu YJ, van Oeveren W, Akkerman C, et al. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:917-22.
8. 8. Pekna M, Hagman L, Haldén E, Nilsson UR, Nilsson B, Thelin S. Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Ann Thorac Surg 1994;58:421-4.
9. 9. Aldea GS, Doursounian M, O'Gara P, et al. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. Ann Thorac Surg 1996;62:410-8.
10. 10. Babikian VL, Hyde C, Pochay V, et al. Clinical correlates of high-intensity transient signals detected on transcranial Doppler sonography in patients with cerebrovascular disease. Stroke 1994;25:1570-3.
11. 11. Gavrilescu T, Babikian VL, Cantelmo NL, et al. Cerebral embolism during carotid endarterectomy. Am J Surg 1995; 170:159-64.
12. 12. Barbut D, Yao FS, Hager DN, et al. Comparison of transcranial Doppler and transesophageal echocardiography to monitor emboli during coronary artery bypass surgery. Stroke 1996;27:87-90.
13. 13. Baker AJ, Naser B, Benasoria M, et al. Cerebral emboli during coronary artery bypass grafting using different cardioplegia techniques. Ann Thorac Surg 1995;59:1187-91.
14. 14. Clarke RE, Brillman J, Davis DA, et al. Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. J Thorac Cardiovasc Surg 1995;109:247-57.
15. 15. Mahana EP, Blumenthal JA, White WD. Defining neuropsychological deficits after coronary artery surgery. Ann Thorac Surg 1996;61:1342-7.
16. 16. Ovrum E, Brosstad F, Åm Holen E, et al. Effect on coagulation and fibrinolysis with reduced vs. full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation 1995;92:2579-84.
17. 17. Gorman RC, Ziats NP, Gikakis N, et al. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111: 1-12.
18. 18. Edmunds LH Jr. Surface-bound heparin: panacea or peril? Ann Thorac Surg 1994;58:285-6.
19. 19. Kuitunen AH, Heikkila LJ, Salmenpera MT. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation. Ann Thorac Surg 1997;63:438-44.
20. 20. Aranki SF, Rizzo RJ, Adams DH, et al. Single-clamp technique, an important adjunct to myocardial and cerebral protection in coronary operations. Ann Thorac Surg 1994;58: 296-302.
21. 21. Pugsley W, Klinger L, Paschalis C, et al. The impact of microemboli during cardiopulmonary bypass on neuropsychological function. Stroke 1994;25:1393-9.
22. 22. Barbut D, Lo YW, Gold JP, et al. Impact of embolization during coronary artery bypass grafting on outcome and length of stay. Ann Thorac Surg 1997;63:998-1002.
23. 23. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary artery surgery. N Engl J Med 1996;335:1857-63.
24. 24. Ovrum E, Mollnes TE, Fosse E, et al. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. Ann Thorac Surg 1995;60:1755-61.